...

Logo Pasino du Havre - Casino-Hôtel - Spa
in partnership with
Logo Nextory

Germany to allow some depressed patients to try psilocybin amid psychedelic medicine boom

Business • Jul 31, 2025, 12:15 AM
3 min de lecture
1

Germany’s medicine regulator will allow certain patients with treatment-resistant depression to try psilocybin therapy, a major shift as psychedelics inch closer to mainstream medicine.

It is the first time in the European Union that psilocybin – the hallucinogenic compound in magic mushrooms – will be made available through a compassionate use scheme, in which patients with serious or life-threatening illnesses can get access to drugs that have not yet been approved.

In Germany, psilocybin will only be prescribed in “justified exceptional cases,” according to the Central Institute of Mental Health (CIMH), which asked regulators to greenlight the programme.

“This is an enormously important step that expands our scope for action,” Dr Gerhard Gründer, head of CIMH’s molecular neuroimaging department, said in a statement.

In some cases, psilocybin therapy “can be a medically and ethically justifiable option, provided it is carried out under strictly controlled conditions and with careful medical supervision,” Gründer added.

Depression is a common mental health problem, but approximately 20 per cent to 30 per cent of people with depression do not respond well to standard treatments, CIMH said.

Studies have shown that psilocybin could be a promising alternative for these patients. The drug is thought to foster connections between different regions of the brain, helping people let go of excessive self-focus and rumination, according to scientists from the United Kingdom and United States.

But sceptics have warned that studies on psychedelic drugs can be hard to replicate.

Growing interest in psychedelics

The decision from Germany’s Federal Institute for Drugs and Medical Devices (BfArM) reflects growing interest in psychedelic therapies, including psilocybin and MDMA, as a treatment for mental health issues such as depression, anxiety, addiction, and post-traumatic stress disorder (PTSD).

Earlier this month, the Czech Republic legalised the medical use of psilocybin for conditions such as depression.

Meanwhile, the first EU-funded trial on psychedelic medicines launched last year to test whether psilocybin can alleviate anxiety and depression among patients with progressive diseases such as multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS). 

Other clinical trials are also underway in Europe, including in Germany, though full approval for psilocybin is not expected in Germany for several years.

In the meantime, the Psychedelic Access And Research European Alliance (PAREA), a nonprofit advocacy group, said compassionate use programmes can complement clinical trials by offering real-world data on these treatments and ensuring they are available for “patients who cannot wait” for full approval.

CIMH expects that many patients will be interested in Germany’s limited access scheme.

“Experience from Switzerland shows that demand far exceeds the available supply,” Gründer said.

“We must therefore continue to work on bringing psychedelics such as psilocybin into standard care for the treatment of mental illness,” he added.


Today

EU Commission 'surprised' by German finance minister's jibe on trade deal 
Business • 3:10 PM
2 min
The European Commission defended its US trade deal, saying it emerged from clear consultation with member states - including Germany - following a jibe by German Finance Minister Lars Klingbeil criticising the EU’s weakness in negotiations with the US.
Read the article
The cyber gulag: How Russia tracks, censors, and controls its citizens online
Business • 1:28 PM
9 min
Going online in Russia can be frustrating, complicated, and even dangerous.
Read the article
Switzerland scrambles to ink trade deal with US amid certain 'economic blow' due to tariffs
Business • 10:24 AM
6 min
The tariffs, which come into effect on Thursday, are estimated to affect around 60% of Swiss exports to the United States, its largest market for its exports of pharmaceuticals, watches, machinery and chocolate.
Read the article
Tariff showdown shatters once robust populist alliance between Trump and Modi
Business • 10:17 AM
11 min
Once allies during the populist wave launched in Trump's first term, the US president and Indian PM Narendra Modi are now on a collision course over tariffs and Washington’s warming ties with Pakistan.
Read the article
China reports thousands of chikungunya cases amid outbreak of mosquito-borne virus
Business • 10:09 AM
4 min
In the hardest-hit city of Foshan, patients have been hospitalised and residents are encouraged to take steps to prevent the virus from spreading.
Read the article
BP launches cost-cutting scheme despite beating profit expectations
Business • 9:45 AM
3 min
The business review comes just a few months after BP said it would save $4bn to $5bn by the end of 2027, relative to 2023 costs.
Read the article
Amid brutal heatwaves, Spain sees one of its worst months for heat-related deaths
Business • 8:48 AM
2 min
Spain reported 1,060 deaths attributed to high temperatures in July, up significantly from the same period a year earlier.
Read the article
The world nearly beat polio. Here’s what got in the way
Business • 8:23 AM
8 min
Fake immunisation records, an imperfect vaccine, and leadership missteps have enabled polio’s comeback, an investigation found.
Read the article
This veteran can now drive again after losing all four limbs during Russia’s war in Ukraine
Business • 6:00 AM
3 min
With state-of-the-art prosthetics and a lot of work in rehabilitation, Mykola Shot has regained much of his independence and mobility.
Read the article
Perimenopause: What are the symptoms, and why are women calling it ‘cougar puberty?’
Business • 5:00 AM
8 min
Women are rebranding perimenopause as ‘cougar puberty’ on social media, encouraging open discourse on a historically under-researched yet near-universal health issue.
Read the article
Europe’s M&A market is alive and kicking - in spite of the odds
Business • 4:46 AM
8 min
Geopolitical unrest and trade uncertainty are complicating mergers and acquisitions (M&A). Despite the volatility, battle-hardened executives are pushing ahead with dealmaking.
Read the article
OpenAI adds mental health safeguards to ChatGPT, saying chatbot has fed into users’ ‘delusions’
Business • 12:24 AM
3 min
OpenAI says it is redesigning its AI chatbot to better detect signs of mental or emotional distress.
Read the article
Most European companies rely on US tech giants to operate their businesses, study warns
Business • 12:23 AM
6 min
About three in four European businesses rely on US companies for email services and their tech stack, a new analysis has found.
Read the article